I get that the trial might be delayed, so costs pushed back, but no trial at all?
Also, they could be positive about pediatric approval, which would provide funds for trials, and give confidence in paying down debt.
What exactly did BP say?
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-105
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.010(1.02%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 95.5¢ | $6.248M | 6.438M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 116040 | 7 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |